Home » Blog » Tennessee Oncology & BCBS-Tennessee Team Up, & CMS Reopens ACA Enrollment Period

Tennessee Oncology & BCBS-Tennessee Team Up, & CMS Reopens ACA Enrollment Period


IP Blog | Dave Melin | February 22, 2015

BioBlog Weekly oncologyThis week in healthcare, Tennessee Oncology, BCBS-Tennessee and Via Oncology launch a pilot oncology clinical pathways program designed to provide better patient outcomes and lower costs, and CMS announced ACA enrollment extension period for Americans who may face penalties in 2015.

BlueCross, Tennessee Oncology Pilot Digital Tools to Improve Care, Experience for Cancer Patients

BlueCross BlueShield of Tennessee and Tennessee Oncology are collaborating on a six-month pilot program to support physicians as they: “use evidence-based care pathways, integrate clinical predictive analytics, and share electronic medical records across care teams.”

ACA enrollment extension may end up costing insurers

Recently, the government announced it would be extending the ACA enrollment period till February 22nd. This announcement came partially because of bad weather in the Northeast but more so because 2015 is the first year that people without insurance will face a fine. What does this mean for insurers? Potentially more risk.

What Funders Can Do to Advance Payment Reform

As different organizations continue to explore alternate payment methods, a group of funders digs into six ways that grant-making organizations can answer the question of “where more work needs to occur to ensure that alternative payment models succeed in achieving broad application and realize their full potential.”

CMS will re-open enrollment for Americans facing tax penalties

The Centers for Medicare and Medicaid Services have announced they will have a special enrollment period specifically for Americans who recently found that they will face a penalty in 2015 unless they get coverage. The enrollment period for Healthcare.gov will begin March 15 and run through April 30.

U.S. cancer survival rates improving

A new study out of Vanderbilt University has found that “Men and women ages 50 to 64, who were diagnosed in 2005 to 2009 with a variety of cancer types, were 39 to 68 percent more likely to be alive five years later, compared to people of the same age diagnosed in 1990 to 1994.”

Activist Hedge Fund Seeks Firing of Ariad Pharma CEO Berger

Last week Sarissa Capital, the largest shareholder of Ariad Pharmaceuticals, announced it would be “nominating two directors for election to the company’s board with the intent to replace [founder and CEO Harvey] Berger and another incumbent director, Wayne Wilson, both of whom are up for re-election.”

Want more health care landscape updates and insights? Follow us on Twitter @innovpartners.


Topics in this Post:



Leave a Comment

Your email address will not be published. Required fields are marked *